LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
81.09
-0.15 (-0.18%)
At close: Aug 1, 2025, 4:00 PM
81.04
-0.05 (-0.06%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Company Description

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.

The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services.

It also provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular and porcine patches; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries.

In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures.

It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001.

LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

LeMaitre Vascular, Inc.
LeMaitre Vascular logo
CountryUnited States
Founded1983
IPO DateOct 19, 2006
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees664
CEOGeorge LeMaitre

Contact Details

Address:
63 Second Avenue
Burlington, Massachusetts 01803
United States
Phone781 221 2266
Websitelemaitre.com

Stock Details

Ticker SymbolLMAT
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001158895
CUSIP Number525558201
ISIN NumberUS5255582018
SIC Code3841

Key Executives

NamePosition
George W. LeMaitreChairman and Chief Executive Officer
David B. RobertsPresident and Director
Trent G. KamkeSenior Vice President of Operations
Dr. George D. LeMaitre FACS, M.D.Founder and Chairman of Scientific Advisory Board
Dorian LeBlanc CPAChief Financial Officer
Kimberly L. CieslakVice President of Marketing
Daniel J. MumfordSenior Director of Human Resources
Jonathan W. NgauSenior Vice President of Information Technology
Maik D. HelmersSenior Vice President of Sales ? Central Europe
Ryan H. ConnellySenior Vice President of Advanced Manufacturing Engineering

Latest SEC Filings

DateTypeTitle
Jun 3, 20258-KCurrent Report
May 30, 2025SDForm - SD
May 12, 2025144Filing
May 9, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
May 8, 202510-QQuarterly Report
May 1, 20258-KCurrent Report
Apr 29, 2025SCHEDULE 13G/AFiling
Apr 17, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 17, 2025DEF 14AOther definitive proxy statements
Mar 13, 2025144Filing